Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma

NCT03023527 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Safety

Conditions

Multiple Myeloma

Interventions

DRUG: Nivolumab
DRUG: Pomalidomide
DRUG: Dexamethasone
DRUG: Elotuzumab

Sponsor

PETHEMA Foundation

Collaborators

[object Object]
[object Object]
[object Object]